DNA shed from colon cancers into bloodstream successfully guides chemotherapy after surgery: Helps clarify the benefit of chemotherapy in stage II cancers
A new research study showed that circulating tumor DNA (ctDNA) — genetic material shed from tumors into the bloodstream — can identify stage II colon cancer patients who can most benefit from chemotherapy following surgery and spare other patients the need for this form of treatment. The multi-institutional, international study, led by researchers at the […]